HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Mengji Lu Selected Research

Immunomodulation

11/2015Current status of immunomodulatory therapy in chronic hepatitis B, fifty years after discovery of the virus: Search for the "magic bullet" to kill cccDNA.
10/2015The Woodchuck, a Nonprimate Model for Immunopathogenesis and Therapeutic Immunomodulation in Chronic Hepatitis B Virus Infection.
2/2015Therapeutic vaccination and immunomodulation in the treatment of chronic hepatitis B: preclinical studies in the woodchuck.
9/2014Poly(I:C) treatment leads to interferon-dependent clearance of hepatitis B virus in a hydrodynamic injection mouse model.
2/2014Interaction of viruses with host immune system and immunomodulation in chronic viral infections.
3/2008Combination of an antiviral drug and immunomodulation against hepadnaviral infection in the woodchuck model.
6/2007Immunomodulation as an option for the treatment of chronic hepatitis B virus infection: preclinical studies in the woodchuck model.
2/2006Immunomodulation by topical particle-mediated administration of cytokine plasmid DNA suppresses herpetic stromal keratitis without impairment of antiviral defense.
5/2005Immunization with the gene expressing woodchuck hepatitis virus nucleocapsid protein fused to cytotoxic-T-lymphocyte-associated antigen 4 leads to enhanced specific immune responses in mice and woodchucks.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Mengji Lu Research Topics

Disease

97Infections
04/2024 - 08/2002
35Chronic Hepatitis B
12/2022 - 09/2003
20Hepatocellular Carcinoma (Hepatoma)
04/2024 - 08/2010
18Virus Diseases (Viral Diseases)
10/2023 - 01/2002
13COVID-19
01/2023 - 01/2020
12Hepatitis B
12/2023 - 04/2003
8Neoplasms (Cancer)
04/2024 - 12/2012
8Hepatitis
12/2023 - 10/2002
6Persistent Infection
12/2023 - 09/2004
4Viremia
01/2022 - 02/2014
3Cytokine Release Syndrome
01/2023 - 12/2017
3Communicable Diseases (Infectious Diseases)
10/2022 - 08/2007
3Reinfection
01/2022 - 08/2002
3Coinfection
07/2021 - 05/2014
3Inflammation (Inflammations)
12/2020 - 08/2012
3Liver Failure
01/2019 - 03/2006
2Chronic Hepatitis (Chronic Active Hepatitis)
12/2023 - 07/2021
2Necrosis
01/2023 - 03/2010
2Acute Liver Failure (Fulminant Hepatic Failure)
01/2019 - 03/2006
2Liver Diseases (Liver Disease)
01/2019 - 09/2011
2Porcine Reproductive and Respiratory Syndrome (PRRS)
01/2019 - 12/2014
1Carcinogenesis
04/2024
1Polyploidy
01/2023
1Paroxysmal nonkinesigenic dyskinesia
01/2023
1Hypoxia (Hypoxemia)
01/2023
1Aneuploidy (Aneuploid)
01/2023
1Hyperplasia
01/2022

Drug/Important Bio-Agent (IBA)

38Antiviral Agents (Antivirals)IBA
04/2024 - 10/2002
22Hepatitis B Surface Antigens (HBsAg)FDA Link
04/2024 - 03/2006
20Proteins (Proteins, Gene)FDA Link
12/2023 - 08/2007
17VaccinesIBA
01/2022 - 06/2007
13Toll-Like Receptors (Toll-Like Receptor)IBA
10/2022 - 12/2007
12DNA (Deoxyribonucleic Acid)IBA
01/2023 - 02/2006
11InterferonsIBA
10/2023 - 01/2010
11AntibodiesIBA
01/2021 - 04/2003
10CytokinesIBA
05/2020 - 01/2004
9LigandsIBA
01/2018 - 03/2010
7Interferon-alpha (Interferon Alfa)IBA
01/2022 - 10/2002
6Hepatitis B e AntigensIBA
12/2023 - 06/2015
6RNA (Ribonucleic Acid)IBA
01/2022 - 08/2002
6Surface Antigens (Surface Antigen)IBA
01/2018 - 09/2003
5AntigensIBA
12/2023 - 01/2012
4Messenger RNA (mRNA)IBA
12/2023 - 12/2005
4Biomarkers (Surrogate Marker)IBA
01/2023 - 08/2012
4Interleukin-6 (Interleukin 6)IBA
01/2023 - 03/2010
4entecavirFDA Link
01/2016 - 01/2009
4Immunologic Factors (Immunomodulators)IBA
01/2016 - 02/2015
3Neutralizing AntibodiesIBA
01/2022 - 01/2021
3Microtubule-Associated Proteins (Microtubule-Associated Protein 2)IBA
01/2022 - 01/2020
3Toll-Like Receptor 2IBA
01/2020 - 09/2012
3NucleosidesIBA
01/2019 - 02/2013
3NucleotidesIBA
01/2019 - 02/2013
3Therapeutic UsesIBA
01/2018 - 12/2005
3MicroRNAs (MicroRNA)IBA
10/2017 - 12/2007
3Lamivudine (Epivir)FDA Link
06/2014 - 03/2006
2Interferon Type IIBA
10/2023 - 10/2012
2fibrin fragment D (D-dimer)IBA
07/2021 - 01/2020
2Phosphotransferases (Kinase)IBA
01/2021 - 01/2020
2Immunoglobulin G (IgG)IBA
01/2021 - 01/2021
2Alanine Transaminase (SGPT)IBA
01/2021 - 10/2009
2Granzymes (Granzyme)IBA
10/2020 - 01/2020
2InterleukinsIBA
10/2020 - 02/2006
2HexosaminesIBA
01/2020 - 01/2020
2Glucose (Dextrose)FDA LinkGeneric
01/2020 - 01/2020
2Membrane Proteins (Integral Membrane Proteins)IBA
08/2019 - 06/2017
2Hepatitis B Vaccines (Hepatitis B Vaccine)IBA
01/2019 - 01/2014
2ChemokinesIBA
01/2019 - 01/2018
2Pattern Recognition ReceptorsIBA
01/2019 - 12/2014
2Viral DNAIBA
01/2018 - 08/2002
2Immunoglobulins (Immunoglobulin)IBA
01/2017 - 01/2014
2Viral ProteinsIBA
01/2017 - 10/2002
2Doxorubicin (Adriamycin)FDA LinkGeneric
10/2016 - 03/2014
2nasIBA
01/2016 - 06/2014
2Toll-Like Receptor AgonistsIBA
05/2015 - 05/2015
2Poly I-CIBA
09/2014 - 02/2008
2A-Form DNA (A-DNA)IBA
05/2014 - 07/2013
2Interleukin-10 (Interleukin 10)IBA
10/2011 - 02/2006
2DNA VaccinesIBA
03/2008 - 06/2007
1Transaminases (Aminotransferases)IBA
12/2023
1sodium-bile acid cotransporterIBA
12/2023
1Macrophage Migration-Inhibitory FactorsIBA
01/2023
1LuciferasesIBA
01/2023
1NF-kappa B (NF-kB)IBA
01/2023
1NexusIBA
01/2023
1macrophage migration inhibitory factor receptorIBA
01/2023
1ChromatinIBA
01/2023
1Transcription Factors (Transcription Factor)IBA
01/2023
1obatoclaxIBA
12/2022
1Pathogen-Associated Molecular Pattern MoleculesIBA
10/2022
1Viral RNAIBA
01/2022
1Protein Disulfide-IsomerasesIBA
01/2022
1Dynamin IIIBA
01/2022
1Hepatitis B AntigensIBA
07/2021
1L-Lactate Dehydrogenase (Lactate Dehydrogenase)IBA
07/2021
1BilirubinIBA
01/2021
1Aspartate Aminotransferases (Aspartate Transaminase)IBA
01/2021
1phosphatidylinositol 3-phosphateIBA
01/2021

Therapy/Procedure

29Therapeutics
12/2022 - 03/2006
9Immunomodulation
11/2015 - 05/2005
2Drug Therapy (Chemotherapy)
12/2012 - 03/2008